Anti-Inflammatory & Lubricant Eye Drops Franchise in Ahmedabad

Ketorolac + Fluorometholone + Polyvinyl Alcohol Eye Drops Supplier in Mumbai

Ophthalmic Inflammation & Lubrication Distributor in Delhi

Anti-Inflammatory Ophthalmic Pharma Franchise in Bangalore

Ketorolac Fluorometholone Polyvinyl Alcohol Eye Drops Stockist in Hyderabad
Ophthalmic Anti-Inflammatory Eye Drop Manufacturer & Exporter in Chandigarh

Home/Products /ketorolac-tromethamine-fluorometholone-polyvinyl-alcohol-1-4-eye-drop

Ketorine PF Eye Drops

Composition : Ketorolac Tromethamine (0.4%) + Fluorometholone (0.1%) + Polyvinyl Alcohol (1.4%) Eye Drops

Dosage Form : Eye Drops

Packaging Type : Dropper

Packaging : 10ml

Price : ₹0/-

Ketorine PF Eye Drops contain Ketorolac Tromethamine 0.4%, Fluorometholone 0.1%, and Polyvinyl Alcohol 1.4%, a triple-action ophthalmic formulation designed to treat ocular inflammation while providing lubrication and protection to the eye surface.

Ketorolac acts as a non-steroidal anti-inflammatory agent, Fluorometholone reduces ocular inflammation via steroidal action, and Polyvinyl Alcohol moisturizes and protects the ocular surface, providing comprehensive relief from irritation, redness, and discomfort.

From a commercial perspective, Ketorine PF Eye Drops are a high-demand ophthalmic anti-inflammatory-lubricant combination, widely used in eye hospitals, post-operative care, and specialty ophthalmology clinics, ensuring strong repeat prescriptions and steady demand.

Adding Ketorine PF Eye Drops to your portfolio strengthens the ophthalmic anti-inflammatory & lubricant segment, offering long-term growth, enhanced prescriber trust, and robust portfolio differentiation for PCD pharma franchise partners.

Read More

About the Product

Ketorine PF Eye Drops contain Ketorolac Tromethamine 0.4%, Fluorometholone 0.1%, and Polyvinyl Alcohol 1.4%, a triple-action ophthalmic formulation designed to treat ocular inflammation while providing lubrication and protection to the eye surface.

Ketorolac acts as a non-steroidal anti-inflammatory agent, Fluorometholone reduces ocular inflammation via steroidal action, and Polyvinyl Alcohol moisturizes and protects the ocular surface, providing comprehensive relief from irritation, redness, and discomfort.

From a commercial perspective, Ketorine PF Eye Drops are a high-demand ophthalmic anti-inflammatory-lubricant combination, widely used in eye hospitals, post-operative care, and specialty ophthalmology clinics, ensuring strong repeat prescriptions and steady demand.

Adding Ketorine PF Eye Drops to your portfolio strengthens the ophthalmic anti-inflammatory & lubricant segment, offering long-term growth, enhanced prescriber trust, and robust portfolio differentiation for PCD pharma franchise partners.

Common side effects may include mild stinging or burning sensation, blurred vision, temporary eye irritation, or dryness. Rarely, increased intraocular pressure, cataract formation, secondary eye infections, or allergic reactions may occur with prolonged use.

Ketorine PF Eye Drops are indicated for the treatment of ocular inflammatory conditions associated with pain, redness, or dryness, such as post-operative inflammation, allergic conjunctivitis, or other inflammatory eye disorders. It should be used under ophthalmologist supervision.

Use Ketorine PF Eye Drops strictly as prescribed by an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Do not use for extended periods without medical supervision. Discontinue and consult a doctor if severe irritation, vision changes, or allergic reactions occur.

Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation